Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants.

Narahara M, Higasa K, Nakamura S, Tabara Y, Kawaguchi T, Ishii M, Matsubara K, Matsuda F, Yamada R.

PLoS One. 2014 Jun 23;9(6):e100924. doi: 10.1371/journal.pone.0100924. eCollection 2014.

2.

The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group.

Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479.

3.

Application of permanents of square matrices for DNA identification in multiple-fatality cases.

Narahara M, Tamaki K, Yamada R.

BMC Genet. 2013 Aug 21;14:72. doi: 10.1186/1471-2156-14-72.

4.

Nitric oxide promotes survival of cerebral cortex neurons with simultaneous addition of [Fe(II)(β-citryl-L-glutamate)] complex in primary culture.

Hamada-Kanazawa M, Narahara M, Takano M, Min KS, Tanaka K, Miyake M.

Biol Pharm Bull. 2013;36(7):1068-79.

5.

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.

6.

Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.

7.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

8.

A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites.

Orimi S, Mizuno K, Narahara M, Umakosi H, Kaihara M, Hashimoto M.

Ther Apher Dial. 2011 Aug;15(4):411-4. doi: 10.1111/j.1744-9987.2011.00973.x.

PMID:
21884478
9.

β-Citryl-L-glutamate acts as an iron carrier to activate aconitase activity.

Hamada-Kanazawa M, Narahara M, Takano M, Min KS, Tanaka K, Miyake M.

Biol Pharm Bull. 2011;34(9):1455-64.

10.

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.

11.

Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Sezgin E, van Natta ML, Ahuja A, Lyon A, Srivastava S, Troyer JL, O'Brien SJ, Jabs DA; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2011 Jun;151(6):999-1006.e4. doi: 10.1016/j.ajo.2010.11.029. Epub 2011 Mar 10.

12.

Superoxide scavenging and xanthine oxidase inhibiting activities of copper-β-citryl-L-glutamate complex.

Narahara M, Hamada-Kanazawa M, Kouda M, Odani A, Miyake M.

Biol Pharm Bull. 2010;33(12):1938-43.

13.

Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C; Ocular Complications of AIDS Research Group.

Clin Infect Dis. 2010 Oct 15;51(8):947-56. doi: 10.1086/656415.

14.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2010 Nov;117(11):2152-61.e1-2. doi: 10.1016/j.ophtha.2010.03.031. Epub 2010 Jul 29.

15.

beta-Citryl-L-glutamate is an endogenous iron chelator that occurs naturally in the developing brain.

Hamada-Kanazawa M, Kouda M, Odani A, Matsuyama K, Kanazawa K, Hasegawa T, Narahara M, Miyake M.

Biol Pharm Bull. 2010;33(5):729-37.

16.

Ultrastructure of the germ cells in the testis of matrinxã, Brycon cephalus (Teleostei, Characidae).

Romagosa E, Narahara MY, Borella MI, Parreira SF, Fenerich-Verani N.

Tissue Cell. 1999 Dec;31(6):540-4. doi: 10.1054/tice.1999.0064.

PMID:
18627871
17.

Triglyceride accumulation by peroxisome proliferators in rat hepatocytes.

Kawano H, Nagata T, Narahara M, Kanazawa M, Miyake M.

Biol Pharm Bull. 2007 Apr;30(4):627-32.

18.

Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats.

Minami K, Saito T, Narahara M, Tomita H, Kato H, Sugiyama H, Katoh M, Nakajima M, Yokoi T.

Toxicol Sci. 2005 Sep;87(1):296-305. Epub 2005 Jun 23.

19.

Suppression of Sox6 in P19 cells leads to failure of neuronal differentiation by retinoic acid and induces retinoic acid-dependent apoptosis.

Hamada-Kanazawa M, Ishikawa K, Ogawa D, Kanai M, Kawai Y, Narahara M, Miyake M.

FEBS Lett. 2004 Nov 5;577(1-2):60-6.

PMID:
15527762
20.

Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid.

Hamada-Kanazawa M, Ishikawa K, Nomoto K, Uozumi T, Kawai Y, Narahara M, Miyake M.

FEBS Lett. 2004 Feb 27;560(1-3):192-8.

PMID:
14988021
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk